Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis

Background: Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory arthritis of childhood, characterized by various clinical phenotypes associated with variable prognosis. Significant progress has been achieved with the use of biologic treatments, which specifically block pro-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Choida, Varvara, Hall-Craggs, Margaret, Jebson, Bethany R., Fisher, Corinne, Leandro, Maria, Wedderburn, Lucy R., Ciurtin, Coziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884612/
https://www.ncbi.nlm.nih.gov/pubmed/33603671
http://dx.doi.org/10.3389/fphar.2020.635823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884612/
https://www.ncbi.nlm.nih.gov/pubmed/33603671
http://dx.doi.org/10.3389/fphar.2020.635823

Ejemplares similares